학술논문
A phase 2 study of bevacizumab, erlotinib, and atezolizumab in subjects with advanced hereditary leiomyomatosis and renal cell cancer (HLRCC) associated or sporadic papillary renal cell cancer (pRCC)
Document Type
Journal
Author
Montenegro, Gabriela Liliana Bravo; Sharon, Elad; Pickett-Gies, Cheryl Ann; Mac, Lisa; Friend, Julia C.; Purcell, Erin; Akshintala, Srivandana; Glod, John; Mckay, Rana R.; Bilen, Mehmet Asim; Rompre-Brodeur, Alexis; Webster, Brad; Gopal, Nikhil; Malayeri, Ashkan A.; Merino, Maria; Kozel, Zachary; Gurram, Sandeep; Linehan, W. Marston; Srinivasan, Ramaprasad
Source
Subject
Language
English
ISSN
15277755